Finance

Beta
Lists
SYRE:NASDAQ
Spyre Therapeutics Inc
$77.30
-1.50%
(-1.18) 1D
Jun 5, 11:09:15 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYRE...
Open
$77.77
High
$78.90
Low
$76.10
Mkt. cap
6.79B
Avg. vol.
1.04M
Volume
154.17K
52-wk high
$79.54
52-wk low
$13.93
EPS
-$2.50
Beta
3.05
Shares outstanding
86.84M
No. of employees
112
Open
$77.77
High
$78.90
Low
$76.10
Mkt. cap
6.79B
Avg. vol.
1.04M
Volume
154.17K
52-wk high
$79.54
52-wk low
$13.93
EPS
-$2.50
Beta
3.05
Shares outstanding
86.84M
No. of employees
112
Analyst outlook
Analyst Ratings
Based on 16 analysts giving stock ratings to SYRE in the past 3 months
Strong Buy
Buy
16
Hold
0
Sell
0
12 month forecast
Based on 16 Wall Street analysts offering 12 month price targets for SYRE in the last 3 months.
Highest
Current $77.30
$115.00 (+48.77%)
Average
$95.86 (+24.01%)
Lowest
$80.00 (+3.49%)
News stories
From sources across the web
About Spyre Therapeutics Inc
CEO-
Employees112
FoundedJan 1, 2013
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitespyre.com
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.74 / -$0.65
-13.11%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
40.14M
45.25M
44.64M
60.41M
Cost of revenue
40.14M
45.25M
44.64M
60.41M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.79M
11.64M
12.53M
15.23M
Operating expense
11.79M
11.64M
12.53M
15.23M
Total operating expenses
51.94M
56.89M
57.17M
75.64M
Operating income
-51.94M
-56.89M
-57.17M
-75.64M
Other non operating income
-656.00K
40.33M
-12.50M
-30.36M
EBT including unusual items
-36.72M
-11.18M
-62.53M
-69.00M
EBT excluding unusual items
-46.72M
-11.18M
-62.53M
-99.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-36.72M
-11.18M
-62.53M
-69.00M
Net profit margin
-
-
-
-
Earnings per share
-0.49
-0.15
-0.74
-0.74
Interest and investment income
5.87M
5.38M
7.14M
7.00M
Interest expense
-
-
-
-
Net interest expenses
5.87M
5.38M
7.14M
7.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-10.00M
-
-
-30.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more